Wordt geladen...
Effectiveness of imatinib mesylate over etoposide in the treatment of sensitive and resistant chronic myeloid leukaemia cells in vitro
Chronic myeloid leukaemia (CML) is a form of leukaemia derived from the myeloid cell lineage. Imatinib mesylate, the breakpoint cluster region-abelson murine leukeamia kinase inhibitor, is a specific reagent used in the clinical treatment of CML. The DNA topoisomerase II inhibitor, etoposide, is als...
Bewaard in:
| Gepubliceerd in: | Exp Ther Med |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5450554/ https://ncbi.nlm.nih.gov/pubmed/28587395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.4443 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|